pSivida Limited (ADR) (NASDAQ:PSDV)
| CAPS Rating |
|
|---|---|
| Open | $1.23 |
| Previous Close | $1.24 |
| Daily Range | $1.21 - $1.25 |
| 52-Week Range | $1.02 - $5.23 |
| Market Cap | $25.54M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 17,339 |
| Average Daily Volume | 0 |
PSDV
VS S&P 500 (SPY)
How do you think PSDV will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
PSDV Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
PSDV News and Commentary
- These 2 Biotechs Got Crushed – The Motley Fool
- November Catalysts for Biotech and Drug Stocks – Minyanville
- Opening View: DJIA, SPX Set to Follow Overseas Markets into the Red – NASDAQ
- FDA Watch: 6 Biotechs Awaiting FDA Drug Approvals in 2011 – NASDAQ
- Pfizer To Pay PSivida Up To $168.8 Million Under Revised Pact; Shares Up – SmartMoney
- Hidden Stocks for High Returns – The Motley Fool
- 13 Above Average Stocks: Industry Leaders or Boat Anchors in Disguise? – SeekingAlpha
- 19 High Growth Micro Cap Stocks Under $10 – SeekingAlpha
- Why Did My Stock Just Die? – The Motley Fool
- FDA Kicks Dust on Alimera's Fairy Tale – The Motley Fool
- Alimera Gets Unwelcome Christmas Message From FDA – SeekingAlpha
- Wall Street's Best Hidden Stocks – The Motley Fool
- 6 Companies With Upcoming FDA Decisions and Bullish Options Sentiment – SeekingAlpha
- Hidden Stocks for High Returns – The Motley Fool
- 2 Year-End FDA Run-Up Stock Plays – SeekingAlpha
- PSivida Gives Added Iluvien Efficacy, Safety Data; Shares Up – SmartMoney
- UPDATE 1-pSivida's eye therapy meets late-stage goal, shrs soar – Reuters
- A TINY Alternative in Nanotech – The Motley Fool
- Innovation From Down Under – The Motley Fool
- Releasing Nanotech's Potential? – The Motley Fool
RSS Headlines
Fool UK
